Ridgewood Investments LLC Bristol Myers Squibb CO Transaction History

Ridgewood Investments LLC

$201 Million
Q3 2024

A detailed history of Ridgewood Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ridgewood Investments LLC holds 32,180 shares of BMY stock, worth $1.84 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

32,180

Previous 34,092 5.61%

Holding current value

$1.84 Million

Previous $1.42 Million 17.67%

% of portfolio

0.83%

Previous 0.7%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$39.66 - $51.75 $75,829 - $98,946	-1,912 Reduced 5.61%	32,180 $1.67 Million
Q2 2024 Jul 29, 2024	BUY	$40.25 - $52.99 $117,167 - $154,253	2,911 Added 9.34%	34,092 $1.42 Million
Q1 2024 Apr 10, 2024	BUY	$47.98 - $54.4 $71,154 - $80,675	1,483 Added 4.99%	31,181 $1.69 Million
Q4 2023 Jan 11, 2024	BUY	$48.48 - $57.85 $4,314 - $5,148	89 Added 0.3%	29,698 $1.52 Million
Q3 2023 Oct 20, 2023	BUY	$57.89 - $64.73 $637,137 - $712,418	11,006 Added 59.16%	29,609 $1.72 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $585,240 - $649,817	9,186 Added 97.55%	18,603 $1.19 Million
Q4 2022 Jan 19, 2023	BUY	$68.48 - $81.09 $6,916 - $8,190	101 Added 1.08%	9,417 $0
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $331,800 - $365,428	-4,569 Reduced 32.91%	9,316 $717,000
Q1 2022 Apr 11, 2022	SELL	$61.48 - $73.72 $102,364 - $122,743	-1,665 Reduced 10.71%	13,885 $1.01 Million
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $17,590 - $20,506	328 Added 2.15%	15,550 $970,000
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $88,755 - $103,965	-1,500 Reduced 8.97%	15,222 $901,000
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $577,620 - $629,028	-9,330 Reduced 35.81%	16,722 $1.12 Million
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $89,069 - $100,176	-1,501 Reduced 5.45%	26,052 $1.65 Million
Q3 2020 Oct 14, 2020	BUY	$57.43 - $63.64 $56,625 - $62,749	986 Added 3.71%	27,553 $1.66 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $10,580 - $12,369	-193 Reduced 0.72%	26,567 $1.56 Million
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $165,091 - $239,915	-3,558 Reduced 11.74%	26,760 $1.49 Million
Q4 2019 Jan 15, 2020	BUY	$49.21 - $64.19 $79,080 - $103,153	1,607 Added 5.6%	30,318 $1.95 Million
Q3 2019 Oct 23, 2019	BUY	$42.77 - $50.71 $10,606 - $12,576	248 Added 0.87%	28,711 $1.46 Million
Q2 2019 Jul 12, 2019	BUY	$44.62 - $49.34 $455,882 - $504,106	10,217 Added 56.0%	28,463 $1.29 Million
Q1 2019 Apr 15, 2019	BUY	$45.12 - $53.8 $267,696 - $319,195	5,933 Added 48.18%	18,246 $870,000
Q3 2018 Oct 30, 2018	BUY	$55.19 - $62.25 $22,076 - $24,900	400 Added 3.36%	12,313 $764,000
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $15,159 - $18,894	300 Added 2.58%	11,913 $659,000
Q1 2018 Apr 17, 2018	SELL	$59.92 - $68.98 $23,968 - $27,592	-400 Reduced 3.33%	11,613 $735,000
Q4 2017 Jan 12, 2018	SELL	$59.94 - $65.35 $11,988 - $13,069	-200 Reduced 1.64%	12,013 $736,000
Q3 2017 Nov 15, 2017	BUY	$55.23 - $63.74 $674,523 - $778,456	12,213	12,213 $778,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgewood Investments LLC with notifications on news.

Account

Ridgewood Investments LLC Bristol Myers Squibb CO Transaction History